Error message

Deprecated function: Using ${var} in strings is deprecated, use {$var} instead in include_once() (line 1445 of /home/patently/domains/xepc.eu/public_html/includes/bootstrap.inc).
Deprecated function: Using ${var} in strings is deprecated, use {$var} instead in include_once() (line 1445 of /home/patently/domains/xepc.eu/public_html/includes/bootstrap.inc).
Deprecated function: Optional parameter $type declared before required parameter $nid is implicitly treated as a required parameter in include_once() (line 1445 of /home/patently/domains/xepc.eu/public_html/includes/bootstrap.inc).

T 2177/12 () of 24.7.2013

European Case Law Identifier:

ECLI:EP:BA:2013:T217712.20130724

Date of decision:

24 July 2013

Case number:

T 2177/12

Application number:

IPC class:

A61M 39/02
A61M 39/04

Language of proceedings:

EN

Distribution:

D

Download and more information:

Decision text in EN (PDF, 162Â KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in:	EN
Versions:	Unpublished

Title of application:

Power injector system for injecting contrast media into an intravenous line

Applicant name:

C.R.Bard, Inc.

Opponent name:

AESCULAP AG & Co. KG
Fresenius Kabi Deutschland GmbH
pfm medical ag

Board:

3.2.02

Headnote:

-

Relevant legal provisions:

European Patent Convention Art 68
European Patent Convention Art 101
European Patent Convention Art 105a
European Patent Convention Art 107
European Patent Convention Art 112(1)
European Patent Convention Art 113(2)
Rules of procedure of the Boards of Appeal Art 16(1)(e)
European Patent Convention R 71(3)
European Patent Convention R 91

Keywords:

Adversely affected (no)
Admissibility of the appeal (no)
Referral to Enlarged Board (no)
Apportionment of costs (no)

Catchwords:

-

Cited decisions:

G 0009/93
T 0329/88
T 0961/00
T 0655/01

Citing decisions:

T 0220/12
T 0964/14
T 0796/15

Source: http://www.epo.org/law-practice/case-law-appeals/recent/t122177eu1.html

Date retrieved: 17 May 2021

16 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

X A.68 EPC Effect of revocation or limitation of the European patent

X A.101 EPC Examination of the opposition – Revocation or maintenance of the European patent

X A.105a EPC Article 105a Request for limitation or revocation

X A.107 EPC Persons entitled to appeal and to be parties to appeal proceedings

X A.112 EPC Decision or opinion of the Enlarged Board of Appeal

X A.113 EPC Right to be heard and basis of decisions

EPC Implementing Rules

X R.71 EPC Examination procedure

X R.91 EPC Responsibility for proceedings

Case Law Book: III Amendments

X CLR III R 2.3 Filing of opposition or appeal

Case Law Book: IV Divisional Applications

X CLR IV D 1 Limitation/revocation – Article 105a EPC- Article 105c EPC

X CLR IV D 2 Requests for revocation during opposition and opposition appeal proceedings

Case Law of the Enlarged Board

X G 0009/93 (Opposition by patent proprietor) of 6.7.1994

General Case Law

X T 0329/88 (Extinction du brevet) of 22.6.1993

X T 0961/00 (Adverse effect/HUBER CORP.) of 9.12.2002

X T 0655/01 (Skin cleaning composition/COLGATE-PALMOLIVE) of 11.11.2005

X T 0964/14 (Kostenverteilung/SULZER) of 23.2.2015